This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
RFP-15-100-SOL-00004: BARDA Chem and Rad/Nuc Animal Model Development. Response date: May 4, 2015.
NASA Research Announcement NNJ14ZSA001N-RADIATION: Funding for Ground-Based Studies in Space Radiobiology. Full text of the solicitation is available on the NASA Research Opportunities homepage. Step 1 proposals due April 3, 2015.
SBIR/STTR Standard Application Deadlines Have Changed. Next receipt date is still April 5th, 2015. After that, NEW dates begin with the September 5th, 2015 receipt date. THERE WILL NOT BE AN AUGUST 5th, 2015 DUE DATE. Read the NIH Guide notice about the changes.
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated April 17, 2015